Cell and Gene Therapy News

Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatmentJun 17, 2016
Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responsesJun 6, 2016
Treating B cell malignancies with the patients’ own T cells modified so as to target specific B cell markers has shown clinical success.
Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancerApr 4, 2016
Baylor College of Medicine researchers have discovered that CTLA-4 is produced and secreted by dendritic cells, which are the ‘generals’ of the T cells in the battle against cancer.
Heslop named director of Center for Cell and Gene TherapyApr 1, 2016
The Baylor College of Medicine Board of Trustees named Dr. Helen Heslop as director of the Center for Cell and Gene Therapy.
Grants support Baylor researchers’ work on immunotherapy for leukemiaOct 2, 2015
Two Baylor researchers have received Translational Research Grants for projects that use immunotherapy approaches to treat leukemia.
Safety switch preserves beneficial effects of cell therapyMay 14, 2015
Researchers have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Novel cell therapy from 'naïve' cells recognizes, attacks high-risk viruses for first time in cord blood transplant patientsApr 29, 2015
Virus-specific cell therapy used in cord blood transplant patients successfully prevented 3 of the most problematic post-transplant viruses affecting this group of patients – cytomegalovirus, Epstein-Barr virus, and adenovirus.
Grant supports research on potential immunotherapy treatment for neuroblastomaDec 30, 2014

Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.

Developmental transcription factors oversee glioma sub-typesOct 6, 2014
Researchers find transcription factors NFIA, Sox10 play important roles in the development of different subtypes of deadly brain tumors.
Dr. Malcolm Brenner receives prestigious lifetime achievement honor from Human Gene Therapy journal Aug 5, 2014
Renowned cell and gene therapy clinician-scientist Dr. Malcolm Brenner has received the prestigious Pioneer Award from the journal Human Gene Therapy.